Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 09 05 2012
accepted: 23 07 2012
pubmed: 23 4 2014
medline: 17 7 2019
entrez: 23 4 2014
Statut: ppublish

Résumé

Highly infectious diseases (HIDs) are defined as being transmissible from person to person, causing life-threatening illnesses and presenting a serious public health hazard. In most European Union member states specialized isolation facilities are responsible for the management of such cases. Ground ambulances are often affiliated with those facilities because rapid relocation of patients is most desirable. To date, no pooled data on the accessibility, technical specifications and operational procedures for such transport capacities are available. During 2009, the 'European Network for HIDs' conducted a cross-sectional analysis of hospitals responsible for HID patients in Europe including an assessment of (a) legal aspects; (b) technical and infrastructure aspects; and (c) operational procedures for ground ambulances used for HID transport. Overall, 48 isolation facilities in 16 European countries were evaluated and feedback rates ranged from 78% to 100% (n = 37 to n = 48 centres). Only 46.8% (22/47) of all centres have both national and local guidelines regulating HID patient transport. If recommended, specific equipment is found in 90% of centres (9/10), but standard ambulances in only 6/13 centres (46%). Exclusive entrances (32/45; 71%) and pathways (30/44; 68.2%) for patient admission, as well as protocols for disinfection of ambulances (34/47; 72.3%) and equipment (30/43; 69.8%) exist in most centres. In conclusion, the availability and technical specifications of ambulances broadly differ, reflecting different preparedness levels within the European Union. Hence, regulations for technical specifications and operational procedures should be harmonized to promote patient and healthcare worker safety.

Identifiants

pubmed: 24750421
pii: S1198-743X(15)00535-2
doi: 10.1111/1469-0691.12290
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1-e5

Investigateurs

Norbert Vetter (N)
Mira Kojouharova (M)
Kremena Parmakova (K)
Peter Skinhoej (P)
Heli Siikamaki (H)
Christian Perronne (C)
Olga Adrami (O)
John Lambert (J)
Simone Lanini (S)
Robert Hemmer (R)
Michael Borg (M)
Anne Lise Fjellet (AL)
Arne Broch Brantsæter (AB)
Andrzej Horban (A)
Franc Strle (F)
Antoni Trilla (A)

Informations de copyright

Copyright © 2016. Published by Elsevier Ltd.

Auteurs

S Schilling (S)

Department for Infectious Diseases, Goethe University, Frankfurt, Germany. Electronic address: stefan.schilling@kgu.de.

H C Maltezou (HC)

Department for Interventions in Health-Care Facilities, Hellenic Centre for Disease Control and Prevention, Athens, Greece.

F M Fusco (FM)

Department for Infectious Diseases, National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy.

G De Iaco (G)

Department for Infectious Diseases, National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy.

H-R Brodt (HR)

Department for Infectious Diseases, Goethe University, Frankfurt, Germany.

B Bannister (B)

Department for Infectious Diseases, Royal Free Hospital, London, UK.

P Brouqui (P)

Research Unit on Emerging Infectious and Tropical Diseases (URMITE), Marseilles, France.

G Carson (G)

Department for Infectious Diseases, Health Protection Agency, UK.

V Puro (V)

Department for Infectious Diseases, National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy.

R Gottschalk (R)

Department of Health, Frankfurt, Germany.

G Ippolito (G)

Department for Infectious Diseases, National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH